(Date:11/21/2009)...y, November 20,2009 / b3c newswire / - KINAXO Bi...financing round, gaining two new investors in the ...me KINAXO reports that Jrgen Schumacher has been e...ard. , KINAXO shareholders Axel Ullrich, Hellmut...institutional investors Mountain Partners, BioM, H...
(Date:11/20/2009)...ort published in the November 2009 issue of the jo...ntists show how a family of genes (1-aminocyclopro...ponsible for production of ethylene. This gas affe...formation lays the foundation for future genetic m...nt, able to survive and thrive in difficult terrai...
(Date:11/20/2009)...ise measurements of plasma lipoprotein concentrati...roscopy (NMR), researchers led by Daniel Chasman a... School in Boston, MA, the Framingham Heart Study ...ckholm, Sweden and Oxford, England performed genet...ong 17,296 women of European ancestry from the Wom...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3It's a gas: New discovery may lead to heartier, high-yielding plants 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 1Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 3NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 1NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 2NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 3Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 1Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 2Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 3Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 4...ken a "snapshot" of a Velcro-like protein on a cel...irus, a linkup thought to initiate the early stage...squitoes, infects more than 50 million people annu... tropical regions. , During the earliest stages o...bohydrate recognition domain," or CRD, of a key bi...
... molecule which they believe could ultimately lead... genetically modified tobacco. Writing in Plant Bi...agues from St George,s, University of London along... they have overcome a major barrier that has so fa...ally viable "bioreactors" for vaccines. , By creat...
...ls and immune cells called macrophages may be a so...the effectiveness of androgen antagonists, the mos...er, according to a new study by researchers at the... of Medicine. , Male hormones called androgens a...owth of the prostate gland, and anti-androgen trea...
Other Biology News:Biologists visualize protein interaction that may initiate viral infection 2Biologists visualize protein interaction that may initiate viral infection 3Do plants have the potential to vaccinate against HIV? 2Macrophage signaling may affect hormone resistance in prostate tumors 2(Date:11/20/2009).... 20 Cell Therapeutics, ...that the Ninth Circuit Court of Appeals reversed a...ld be allowed to pursue all of its claims against ...ict Court for trial. CTI filed a complaint agains...sement consultant for CTI,s product TRISENOX, in 2...
(Date:11/19/2009)...19 Danish Prince Joachim inaugurat...plant in Kalundborg, Denmark, on Wednesday, Novemb...d largest 2nd generation ethanol demonstration bio...d in the plant,s innovative process for converting...as the first to market with commercial enzymes for...
(Date:11/19/2009)...9 NeoStem, Inc. (NYSE Am...ollowing letter to its shareholders, discussing th...hina Biopharmaceuticals Holdings, Inc. (CHBP), an ... People,s Republic of China. The merger gives NeoS...maceutical Co. Ltd., CHBP,s primary operating subs...
(Date:11/19/2009)...9 /PRNewswire/ - Aegera Therapeutics Inc. announce...mized Phase 2B study of AEG35156, a targeted antis...iple oncology indications. ,, The study, entitl...X-Linked Inhibitor of Apoptosis (XIAP) Antisense A...bine and Idarubicin in AML Following Failure of a ...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2...um to be held April 17, 2008, GRAND RAPIDS, Mich....Initiative (WMSTI) is accepting exhibitor applicat...nual Life Science Business,Showcase, Night at the ..., Night at the Museum is seeking regional exhibit... from up-and-coming startups in pharma research to...
... Feb. 19 National Stem,Cell Holding, Inc. (OTC: N... Arnold Securities, Inc. ("BMA Securities") to pro... respect to assisting and advising the,company wit...urities is a FINRA member full service brokerage f...al services, which include: market,making, institu...
...February 19 ChemAxon, a software,solutions provid...of,version 5 of their cheminformatics toolkits, Ma...n Marvin user friendliness, Markush enumeration an... Oracle Cartridge,performance., Marvin & JChem is...I,s),and graphic user interfaces (GUI,s) used by l...
Other Biology Technology:West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase 2National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000 2ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance 2CM Galactose Broth from Aestus Pharmaceuticals Corp.
Yeast Nitrogen Base from Invitrogen
Rabbit Anti-SLC25A13 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Dr. P Set - Monkey (Cynomolgus) Normal Tissue: Small Intestine from BioChain
Biology Products: